Inventor
JUN SUNG SOO
KR21 patents
⚠️ This page may combine multiple inventors who share the name “JUN SUNG SOO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
KIM SUNG WUK
12 patentsUS9133110B2Sep 15, 2015
Biguanide derivative, preparation method thereof, and pharmaceutical composition containing same as an active ingredient
KIM SUNG WUK14 citations91
US9416098B2Aug 16, 2016
Biguanide derivative, a preparation method thereof and a pharmaceutical composition containing the biguanide derivative as an active ingredient
KIM SUNG WUK6 citations82
US8648111B2Feb 11, 2014
N1-2-thiophene-2-ylethyl-N2-substituted biguanide derivate, preparation method thereof, and pharmaceutical composition containing the same as active ingredients
KIM SUNG WUK9 citations82
US8058312B2Nov 15, 2011
N, N-dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same
KIM SUNG WUK10 citations82
US8076377B2Dec 13, 2011
N,N-dimethyl imidodicarbonimidic diamide dicarboxylate, method for producing the same and pharmaceutical compositions comprising the same
KIM SUNG WUK10 citations81
US8642647B2Feb 4, 2014
N1-benzo[1,3]dioxol-5-ylmethyl-N2-substituted biguanide derivative, preparation method thereof, and pharmaceutical composition containing same
KIM SUNG WUK6 citations71
US8394845B2Mar 12, 2013
Method of using combination preparation comprising angiotensin-II-receptor blocker and HMG-CoA reductase inhibitor
KIM SUNG WUK4 citations59
US9068019B2Jun 30, 2015
Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
KIM SUNG WUK1 citations50
US8895500B2Nov 25, 2014
Modified human tumor necrosis factor receptor-I polypeptide or fragment thereof, and method for preparing same
KIM SUNG WUK0 citations50
US8541474B2Sep 24, 2013
N,N-dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same
KIM SUNG WUK1 citations50
US8754037B2Jun 17, 2014
Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
KIM SUNG WUK0 citations39
US8642083B2Feb 4, 2014
Controlled release complex composition comprising angiotensin-II-receptor blockers and HMG-CoA reductase inhibitors
KIM SUNG WUK0 citations38
IMMUNOMET THERAPEUTICS INC
3 patentsUS9464042B2Oct 11, 2016
Biguanide derivative, preparation method thereof, and pharmaceutical composition containing same as an active ingredient
IMMUNOMET THERAPEUTICS INC4 citations82
US9993446B2Jun 12, 2018
Biguanide derivative, a preparation method thereof, and a pharmaceutical composition containing the biguanide derivative as an active ingredient
IMMUNOMET THERAPEUTICS INC1 citations61
US10376480B2Aug 13, 2019
Biguanide derivative, a preparation method thereof, and a pharmaceutical composition containing the biguanide derivative as an active ingredient
IMMUNOMET THERAPEUTICS INC0 citations50